UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses

Journal of affective disorders, 2013-02, Vol.145 (1), p.62-69

2013

Volltextzugriff (PDF)

DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data

Journal of affective disorders, 2013-09, Vol.150 (2), p.378-383

2013

Volltextzugriff (PDF)

Effect of brexpiprazole on weight and metabolic parameters: analysis of a maintenance trial in schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S556-S556

2016

Volltextzugriff (PDF)

P2.f.018 Effect of adjunctive brexpiprazole (OPC-34712) on depressive symptoms in patients with symptoms of anxious distress: results from post-hoc analyses

European neuropsychopharmacology, 2015-09, Vol.25, p.S444-S445

2015

Volltextzugriff (PDF)

Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies

European psychiatry, 2016-03, Vol.33 (S1), p.S109-S109

2016

Volltextzugriff (PDF)

Effect of adjunctive brexpiprazole on functioning in three exploratory, open-label studies in major depressive disorder

European neuropsychopharmacology, 2016-10, Vol.26, p.S406-S406

2016

Volltextzugriff (PDF)

P.2.f.025 Switching from inadequate adjunctive treatments: Open-label study of brexpiprazole effects on depressive symptoms, cognitive and physical functioning

European neuropsychopharmacology, 2015-09, Vol.25, p.S448-S449

2015

Volltextzugriff (PDF)

The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI

European psychiatry, 1997, Vol.12 (5), p.224-231

1997

Volltextzugriff (PDF)

The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability

European psychiatry, 1997, Vol.12 (5), p.232-241

1997

Volltextzugriff (PDF)

P.3.d.071 The effect of brexpiprazole (OPC-34712) in adult outpatients with early-episode schizophrenia: An exploratory study

European neuropsychopharmacology, 2015-09, Vol.25, p.S521-S522

2015

Volltextzugriff (PDF)

P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies

European neuropsychopharmacology, 2015-09, Vol.25, p.S522-S523

2015

Volltextzugriff (PDF)

P.3.d.063 Brexpiprazole (OPC-34712) vs aripiprazole in adults with acute schizophrenia: a multicenter, randomized, open-label, flexible-dose, exploratory study

European neuropsychopharmacology, 2015-09, Vol.25, p.S516-S517

2015

Volltextzugriff (PDF)

P.2.f.026 Adjunctive brexpiprazole (OPC-34712) in young patients with major depressive disorder who are working or at school: an exploratory study

European neuropsychopharmacology, 2015-09, Vol.25, p.S449-S449

2015

Volltextzugriff (PDF)

P.2.e.019 Remission of manic and depressive symptoms with asenapine in patients with mixed episodes

European neuropsychopharmacology, 2012-10, Vol.22, p.S286-S287

2012

Volltextzugriff (PDF)

P.3.d.079 Brexpiprazole (OPC-34712) efficacy and safety as maintenance therapy in adults with schizophrenia: Randomised, double-blind, placebo-controlled study

European neuropsychopharmacology, 2015-09, Vol.25, p.S527-S527

2015

Volltextzugriff (PDF)

DSM-III-R Psychotic Disorders : procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI

European psychiatry, 1998, Vol.13 (1), p.26-34

1998

Volltextzugriff (PDF)

Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine

Current medical research and opinion, 2010-03, Vol.26 (3), p.605-614

2010

Volltextzugriff (PDF)

Does baseline anxiety affect outcome of SSRI treatment in patients with severe depression?

European psychiatry, 2008-04, Vol.23, p.S367-S367

2008

Volltextzugriff (PDF)

Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care

British journal of psychiatry, 1998, Vol.173 (34), p.18-23

1998

Volltextzugriff (PDF)

Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder

British journal of psychiatry, 1996-02, Vol.168 (2), p.169-174

1996

Volltextzugriff (PDF)

Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study

Neuropsychiatric disease and treatment, 2016-01, Vol.12, p.2265-2271

2016

Volltextzugriff (PDF)

Characteristics, recognition and treatment of dysthymics in primary care

European psychiatry, 1998-07, Vol.13 (4), p.198-202

1998

Volltextzugriff (PDF)

P.3.d.037 - Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study

European neuropsychopharmacology, 2017-10, Vol.27, p.S952-S952

2017

Volltextzugriff (PDF)

Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study

European neuropsychopharmacology, 2017-10, Vol.27, p.S952

2017

Volltextzugriff (PDF)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

Neuropsychiatric disease and treatment, 2019-01, Vol.15, p.37-45

2019

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(329)
Mit Volltextzugriff
(311)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(117)
Humans
(107)
Life Sciences & Biomedicine
(106)
Female
(73)
Male
(69)
Middle Aged
(54)
Adult
(53)
Biological And Medical Sciences
(50)
Neurosciences & Neurology
(47)
Medical Sciences
(45)
Psychiatry
(43)
Aged
(40)
Clinical Neurology
(38)
Sciences Biologiques Et Medicales
(31)
Sciences Medicales
(31)
Neurology
(20)
Psychology. Psychoanalysis. Psychiatry
(18)
Neurosciences
(17)
Internal Medicine
(15)
Psychopathology. Psychiatry
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: Results from post hoc analyses

DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data

Effect of brexpiprazole on weight and metabolic parameters: analysis of a maintenance trial in schizophrenia

P2.f.018 Effect of adjunctive brexpiprazole (OPC-34712) on depressive symptoms in patients with symptoms of anxious distress: results from post-hoc analyses

Efficacy and safety of brexpiprazole in schizophrenia: Meta-analysis of three double-blind, randomized, placebo-controlled phase 3 studies

Effect of adjunctive brexpiprazole on functioning in three exploratory, open-label studies in major depressive disorder

P.2.f.025 Switching from inadequate adjunctive treatments: Open-label study of brexpiprazole effects on depressive symptoms, cognitive and physical functioning

The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI

The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability

P.3.d.071 The effect of brexpiprazole (OPC-34712) in adult outpatients with early-episode schizophrenia: An exploratory study

P.3.d.072 Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies

P.3.d.063 Brexpiprazole (OPC-34712) vs aripiprazole in adults with acute schizophrenia: a multicenter, randomized, open-label, flexible-dose, exploratory study

P.2.f.026 Adjunctive brexpiprazole (OPC-34712) in young patients with major depressive disorder who are working or at school: an exploratory study

P.2.e.019 Remission of manic and depressive symptoms with asenapine in patients with mixed episodes

P.3.d.079 Brexpiprazole (OPC-34712) efficacy and safety as maintenance therapy in adults with schizophrenia: Randomised, double-blind, placebo-controlled study

DSM-III-R Psychotic Disorders : procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI

Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine

Does baseline anxiety affect outcome of SSRI treatment in patients with severe depression?

Prevalence and recognition of anxiety syndromes in five European primary care settings. A report from the WHO study on Psychological Problems in General Health Care

Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder

Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study

Characteristics, recognition and treatment of dysthymics in primary care

P.3.d.037 - Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study

Effect of brexpiprazole on long-term remission in adults with schizophrenia: results of an open-label, long-term study

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

Suchergebnisse filtern